SCHEMBL7992992

SCHEMBL7992992

CCCOc1ccc2c(c1)ncn2-c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 17/20 1.00
SRC P12931 8/20 0.74
KDR P35968 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7989591 0.99 FGFR1 (0.97) FGFR1SRCKDR
SCHEMBL7993339 0.94 FGFR1 (1.00) FGFR1SRCKDR
Hydrochloric Acid SCHEMBL7986675 0.93 FGFR1 (0.97) FGFR1SRCKDR
SCHEMBL7986395 0.89 FGFR1 (0.80) FGFR1SRCKDR
Hydrochloric Acid SCHEMBL7975633 0.87 FGFR1 (0.78) FGFR1SRCKDR
SCHEMBL7989532 0.86 FGFR1 (1.00) FGFR1SRCKDR
SCHEMBL7989795 0.85 FGFR1 (1.00) FGFR1SRCKDR
Hydrochloric Acid SCHEMBL7986209 0.85 FGFR1 (0.97) FGFR1SRCKDR
Hydrochloric Acid SCHEMBL7986269 0.84 FGFR1 (0.97) FGFR1SRCKDR
SCHEMBL7987322 0.84 FGFR1 (1.00) FGFR1SRCKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218388-B1 THERAPY OF PROTEIN TYROSINE KINASE MEDIATED CANCER, ATHEROSCLEROSIS, RESTENOSIS, AND PSORIASIS BY ADMINISTERING BENZIMIDAZOLE DERIVATIVE WARNER-LAMBERT COMPANY 2001-04-17 US disclosed
US-5990146-A TREATING PROTEIN TYROSINE KINASE MEDIATED CANCER; ANTICARCINOGENIC AGENTS; ATHEROSCLEROSIS; RESTENOSIS; PSORIASIS; ANTIPROLIFERATIVE AGENTS WARNER-LAMBERT COMPANY (US) 1999-11-23 US disclosed